Focused review discusses characteristics and treatment options of acquired dermal macular hyperpigmentation, suggesting a unified approach to diagnosis and management.
Acquired Dermal Macular Hyperpigmentation (ADMH) encompasses a group of pigmentary disorders—lichen planus pigmentosus, erythema dyschromicum perstans, and Riehl’s melanosis/pigmented cosmetic dermatitis—that present with insidious-onset grey to brown macules and patches due to dermal melanin deposition. Traditionally regarded as distinct entities, these conditions share overlapping clinical, dermoscopic, and histopathological features, leading to the adoption of ADMH as a unifying term. In this focused review, we discuss the pathogenesis, clinical features, diagnostic methods and therapeutic options of ADMH.
No takes yet. Share an insight, caveat, or question.
R et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: